Skip to content

AlveoGene vs Avalyn Pharma

AlveoGene logo

AlveoGene

Transforming Rare Respiratory Disease Outcomes Using Inhaled Genes Therapy

3 employees · est. 2022

VS
Avalyn Pharma logo

Avalyn Pharma

Revolutionizing respiratory care with every breath

58 employees · est. 2011 · Boston, United States

Avalyn Pharma is the older company (2022 vs 2011); Avalyn Pharma is the larger of the two.

Side-by-Side Comparison

AlveoGene Avalyn Pharma
Founded
2022 2011 older
Headquarters
Not tracked yet Boston, United States
Employees
3 58 larger
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Seed Series C
Total Funding
Not tracked yet $272.50M
Funding Rounds
1 3
Services
Not tracked yet Development of inhaled therapies, Drug delivery solutions, Clinical trials
Target Customers
Not tracked yet Patients with rare lung diseases, Healthcare providers, Biopharmaceutical investors
Taxonomy
AlveoGeneRare Respiratory DiseasesInhaled Gene TherapyGene Therapy DevelopmentRespiratory Gene TherapyGTC (Gene Therapy Consortium) +9 Pulmonary Fibrosis TreatmentRespiratory CareInhaled FormulationsInterstitial Lung DiseasesPirfenidoneNintedanib +9
Website
alveogene.com avalynpharma.com
AlveoGene logo

About AlveoGene

AlveoGene is a cutting-edge company with a vision to revolutionize outcomes for rare respiratory diseases through inhaled gene therapy. Established in 2022, the company is a collaboration between Oxford Science Enterprises, Edinburgh Innovations, and Harrington Discovery Institute at University Hosp...

Avalyn Pharma logo

About Avalyn Pharma

Avalyn Pharma, founded in 2011 and headquartered in the United States, is pioneering advancements in the treatment of pulmonary fibrosis. With the slogan, “Revolutionizing respiratory care with every breath,” Avalyn is focused on creating innovative inhaled therapies. The company is reshaping respi...

Also comparing in this category

Comparing more than these two?

Get AlveoGene, Avalyn Pharma and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does AlveoGene compare?

A PDF of AlveoGene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

AlveoGene was founded in 2022, with 3 employees. AlveoGene is a cutting-edge company with a vision to revolutionize outcomes for rare respiratory diseases through inhaled gene therapy. Established in 2022, the company is a collaboration between Oxfo. Avalyn Pharma was founded in 2011, based in Boston, United States, with 58 employees. Avalyn Pharma, founded in 2011 and headquartered in the United States, is pioneering advancements in the treatment of pulmonary fibrosis. With the slogan, “Revolutionizing respiratory care with every.
AlveoGene has raised no disclosed funding and Avalyn Pharma $272.50M. Latest stage: AlveoGene Seed, Avalyn Pharma Series C.
Both work in Biotechnology.

Compare AlveoGene with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AlveoGene on 12 Sep 2024, and Avalyn Pharma on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout